| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7503771 | Drug and Alcohol Dependence | 2016 | 8 Pages |
Abstract
The rate of doctor-shopping for brand ER oxycodone decreased substantially after its reformulation, which did not occur for other prescription opioids. The largest reductions in doctor-shopping occurred with characteristics associated with higher abuse risk such as youth, cash payment and high dose, and with more specific thresholds of doctor-shopping. A higher prescriber and/or pharmacy threshold also increased the magnitude of the decrease, suggesting that it better captured the effect of the reformulation on actual doctor-shoppers.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Howard D. Chilcoat, Paul M. Coplan, Venkatesh Harikrishnan, Louis Alexander,